Interestingly, CD47 immunomediated depletion proved to be effective in preclinical models for NSCLC and evidence indicates a mechanism involving enhanced phagocytosis (Kojima et al., 2016; Weiskopf et al., 2016). Here, CD47 is linked to non-small cell lung carcinoma.